Twist Bioscience Liabilities 2024

Twist Bioscience Aktienanalyse

What does Twist Bioscience do?

Twist Bioscience Corp is a company specializing in the production and applications of synthetic DNA. It was founded in 2013 and is based in San Francisco, California, USA. The company utilizes proprietary technologies to cost-effectively produce high-quality and high-quantity synthetic DNA. The company operates in three business areas: DNA synthesis, biopharmaceuticals, and data storage. The DNA synthesis division is the core of the company and involves the production of synthetic DNA for applications in various industries, including medicine, agricultural science, biotechnology, plastic engineering, and others. The company manufactures customized DNA synthesis products tailored to the needs of its customers, allowing them to accelerate and optimize their research and development projects. Twist Bioscience has also developed a proprietary technology called "Twist Biosensor" that enables rapid and cost-effective analysis of genetic variations. The biopharmaceutical division focuses on the development of therapeutics and diagnostics based on synthetic DNA. Twist Bioscience develops antibodies and proteins that can be used in cancer and immunotherapy, as well as diagnostics. In the data storage field, Twist Bioscience develops solutions for storing large amounts of data on DNA. This technology utilizes the dense and stable structure of DNA to securely and reliably store data in the long term. Twist Bioscience's DNA synthesis products are utilized by researchers, companies, and public institutions in various industries. Customers value not only the wide product portfolio but also the high quality and precision of the products, as well as the speed of order processing. The company operates a number of manufacturing facilities near its customers in Europe and Asia to ensure fast and efficient delivery of its products. This allows Twist Bioscience to have a strong position in the global market. In recent years, the company has achieved significant milestones. In 2018, Twist Bioscience went public and raised a total of $70 million through its IPO. The company has also established partnerships with various other companies and institutions to develop new applications and products. Overall, Twist Bioscience is a growing company specializing in the production and applications of synthetic DNA. With its wide range of high-quality and customized DNA synthesis products, as well as its innovative solutions in the biopharmaceutical and data storage sectors, the company has established a strong market position. Twist Bioscience ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Liabilities Details

Assessing Twist Bioscience's Liabilities

Twist Bioscience's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Twist Bioscience's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing Twist Bioscience's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

Twist Bioscience's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in Twist Bioscience’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about Twist Bioscience stock

What is the level of liabilities of Twist Bioscience this year?

Twist Bioscience has a debt balance of 153 M USD this year.

What were the liabilities of Twist Bioscience compared to the previous year?

The liabilities of Twist Bioscience have increased by -11.05% dropped compared to the previous year.

What are the consequences of high debt for investors of Twist Bioscience?

High liabilities can pose a risk for investors of Twist Bioscience, as they can weaken the company's financial position and impair its ability to meet its obligations.

What consequences do low liabilities have for investors in Twist Bioscience?

Low liabilities mean that Twist Bioscience has a strong financial position and is able to meet its obligations without overburdening its finances.

How does an increase in liabilities of Twist Bioscience affect the company?

An increase in liabilities of Twist Bioscience can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.

How does a reduction in the liabilities of Twist Bioscience affect the company?

A decrease in the liabilities of Twist Bioscience can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.

What are some factors that influence the liabilities of Twist Bioscience?

Some factors that can influence the liabilities of Twist Bioscience include investments, acquisitions, operating costs, and sales development.

Why is the level of liabilities of Twist Bioscience so important for investors?

The liabilities of Twist Bioscience are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.

What strategic measures can Twist Bioscience take to modify the liabilities?

To change its liabilities, Twist Bioscience can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.

How much dividend does Twist Bioscience pay?

Over the past 12 months, Twist Bioscience paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Twist Bioscience is expected to pay a dividend of 0 USD.

What is the dividend yield of Twist Bioscience?

The current dividend yield of Twist Bioscience is .

When does Twist Bioscience pay dividends?

Twist Bioscience pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Twist Bioscience?

Twist Bioscience paid dividends every year for the past 0 years.

What is the dividend of Twist Bioscience?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Twist Bioscience located?

Twist Bioscience is assigned to the 'Health' sector.

Wann musste ich die Aktien von Twist Bioscience kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Twist Bioscience from 9/10/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 9/10/2024.

When did Twist Bioscience pay the last dividend?

The last dividend was paid out on 9/10/2024.

What was the dividend of Twist Bioscience in the year 2023?

In the year 2023, Twist Bioscience distributed 0 USD as dividends.

In which currency does Twist Bioscience pay out the dividend?

The dividends of Twist Bioscience are distributed in USD.